The Cannabinoid CB1/CB2 Agonist WIN55212.2 Promotes Oligodendrocyte Differentiation In Vitro and Neuroprotection During the Cuprizone-Induced Central Nervous System Demyelination.
Journal Information
Full Title: CNS Neurosci Ther
Abbreviation: CNS Neurosci Ther
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Conflict of Interest The authors declare no conflict of interest."
Funding Disclosure
Evidence found in paper:
"The authors would like to thank Dr. Möbius and Torben Ruhwedel (Dept. of Neurogenetics, MPIEM, Göttingen, Germany) for excellent technical support. The work was supported by DFG CNMPB grant CNMPB C1‐6 to Prof Havemann‐Reinecke. We thank the Northern German Addiction Research Federation for kindly financial support of this study to U. Havemann‐Reinecke."
Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025